Podcasts about clinical affairs

LTBS host Dr. Joel Berg sits down with incoming American Academy of Pediatric Dentistry President Dr. Tom Ison to talk about his leadership journey. Dr. Ison shares how he felt the pull to specialize in pediatrics after practicing as a general dentist, and how that choice impacted him as a rural practitioner. He also delves into his agenda for the 25-26 Academy year, including honoring the legacy of the leaders who came before him. Recorded in front of a live audience at AAPD 2025, the conversation is a testament to the importance of professional organizations and the role they play in sharing expert information. Guest Bio: Dr. Thomas G. Ison is in private practice in Newburgh, Ind. He received his dental degree and certificate in pediatric dentistry from the University of Kentucky College of Dentistry and Chandler Medical Center in Lexington, Ky., and completed a Fellowship in Pediatric Dentistry at Indiana University School of Dentistry. He previously held appointments as an assistant professor at the University of Kentucky College of Dentistry and Chief of Dentistry at Norton Children's Hospital, in Louisville. He is a Fellow of the American Academy of Pediatric Dentistry and American College of Dentists, as well as a Diplomate of the American Board of Pediatric Dentistry. He has completed the AAPD Leadership Institute at Kellogg and the Advanced Leadership at Wharton. He served as a consultant to the AAPD Council of Clinical Affairs, District III (now Southeastern) Trustee and is a Past President of the Southeastern Society of Pediatric Dentistry and Kentucky Academy of Pediatric Dentistry. Dr. Ison has been an examiner for the ABPD Oral Clinical Exam as well as committee member and part leader for the Renewal of Certification Examination. He resides in Evansville, Ind., with his wife, Connie, and daughter, Maggie.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Lindsay Dougherty, International Vice President and Division Director of the Motion Picture and Theatrical Trade Division of the International Brotherhood of Teamsters and Principal Officer of Teamsters Local 399, joined the America's Work Force Union Podcast. Dougherty discussed the impact of tax incentives on production locations, the industry's contraction due to streaming and efforts to standardize contracts across the country. Merrilee Logue, Executive Director of the National Labor Office (NLO) at Blue Cross Blue Shield Association (BCBSA), and Dr. Ruthie Fesahazion-Fortune, Project Director for Clinical Affairs at BCBSA, discuss the mental health crisis facing American workers. In this episode of the America's Work Force Union Podcast, they explore common mental health challenges, workplace impacts and BCBSA's strategies to address these issues.

This episode, recorded live at the Becker's 3rd Annual Spring Payer Issues Roundtable, features Dr. Damanjeet Chaubey, Vice President of Clinical Affairs at Clover Health. Dr. Chaubey shares how Clover is leveraging AI-powered technology, proactive care models, and home-based strategies to improve outcomes, reduce costs, and redefine Medicare Advantage.

Are Vaccines Good For Us? Marschall S. Runge, M.D., Ph.D., was born in Austin, Texas, and graduated from Vanderbilt University with a BA in General Biology and a PhD in Molecular Biology. He received his medical degree from the Johns Hopkins School of Medicine and trained in internal medicine at Johns Hopkins Hospital. He was a cardiology fellow and junior faculty member at Massachusetts General Hospital. Dr. Runge's next position was at Emory University, where he directed the Cardiology Fellowship Training Program. He then moved to the University of Texas Medical Branch in Galveston, where he was Chief of Cardiology and Director of the Sealy Center for Molecular Cardiology. He joined the University of North Carolina (UNC) from 2000 – 2014, where he served as Charles Addison and Elizabeth Ann Sanders Distinguished Professor of Medicine, Chair of the Department of Medicine, President of UNC Physicians and Vice Dean for Clinical Affairs. Dr. Runge visits with Mark Alyn.Become a supporter of this podcast: https://www.spreaker.com/podcast/late-night-health-radio--2804369/support.

Are Vaccines Good For Us? Marschall S. Runge, M.D., Ph.D., was born in Austin, Texas, and graduated from Vanderbilt University with a BA in General Biology and a PhD in Molecular Biology. He received his medical degree from the Johns Hopkins School of Medicine and trained in internal medicine at Johns Hopkins Hospital. He was a cardiology fellow and junior faculty member at Massachusetts General Hospital. Dr. Runge's next position was at Emory University, where he directed the Cardiology Fellowship Training Program. He then moved to the University of Texas Medical Branch in Galveston, where he was Chief of Cardiology and Director of the Sealy Center for Molecular Cardiology. He joined the University of North Carolina (UNC) from 2000 – 2014, where he served as Charles Addison and Elizabeth Ann Sanders Distinguished Professor of Medicine, Chair of the Department of Medicine, President of UNC Physicians and Vice Dean for Clinical Affairs. Dr. Runge visits with Mark Alyn.Become a supporter of this podcast: https://www.spreaker.com/podcast/late-night-health-radio--2804369/support.

On Friday March 28th, the Irish Cancer Society (ICS) will celebrate Daffodil Day. It's the charity's biggest fundraising event and aims to raise millions of euros to support cancer patients and progress cancer research. In this episode, Kathy Sheridan is joined by Daffodil Day Ambassador Tara Doonan, who was diagnosed with breast cancer in 2022 at 36 years-old. Tara lives in Cavan but travelled to the Mater Hospital in Dublin for her treatment. In today's episode she talks about the shock of her diagnosis, the road to recovery and the financial impact of cancer, from travel and parking expenses, to the loss of income. Amy Nolan, Director of Clinical Affairs at ICS also joins the conversation to explain how the charity supports patients financially and what needs to change in order to limit costs for those undergoing treatment. But first Irish Times podcast presenter Bernice Harrison is here to discuss some of the biggest stories of the week including a frightening encounter at a Dublin hotel for influencer Chloe Koyce, the harassment of a University of Limerick student at her campus accommodation and the latest in the rumoured feud between Gwyneth Paltrow and Meghan Markle. Hosted on Acast. See acast.com/privacy for more information.

Brían French, brother of the late Eoin French // Amy Nolan, Director of Clinical Affairs with The Irish Cancer Society

KEY MILESTONES AND WHAT'S NEXTSuccessful Phase 1 Trial: Lucid-MS has shown excellent safety with no serious side effects, paving the way for a groundbreaking treatment for MS.Next Major Step: The Phase 2 trial is set for early 2026, with 60 participants.FDA Submission on the Horizon: Plans to submit application to the FDA by late 2025, taking a huge step toward regulatory approval.Massive Market Opportunity: With 2.9 million people worldwide affected by Multiple Sclerosis and the market projected to surpass $30 billion by 2030, Lucid-MS could potentially capture a significant share of this rapidly expanding space.A NEW ERA IN MULTIPLE SCLEROSIS TREATMENTQuantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Lucid-MS is setting the stage to revolutionize MS treatment. Unlike existing therapies that only target immune system responses, Lucid-MS focuses on protecting and repairing myelin, the critical layer around nerve fibers. This novel approach has the potential to slow or even reverse disease progression—offering new hope for millions of MS sufferers.Think of nerves like electrical wires in your body, and myelin as the protective coating around those wires. With Multiple Sclerosis, the immune system attacks this coating (called demyelination), causing damage that leads to muscle weakness, vision problems, and difficulty moving.Most MS treatments try to calm the immune system to slow down the attack. Lucid-MS is different. Instead of focusing on the immune system, it works directly on the myelin to stabilize and protect it from damage.HOW DOES IT WORK? A TOTALLY NEW APPROACH TO TREATING MSThink of nerves like electrical wires in your body, and myelin as the protective coating around those wires. With Multiple Sclerosis, the immune system attacks this coating (called demyelination), causing damage that leads to muscle weakness, vision problems, and difficulty moving.Most MS treatments try to calm the immune system to slow down the attack. Lucid-MS is different. Instead of focusing on the immune system, it works directly on the myelin to stabilize and protect it from damage.WHY IS THIS IMPORTANT?By keeping myelin intact, Lucid-MS may help slow down the progression of MS and prevent disability—something current MS drugs don't do very well.SCIENTIFIC BREAKTHROUGH BACKED BY INDUSTRY RECOGNITIONLucid-MS is backed by cutting-edge research from Dr. Lakshmi Khotra's lab at the University of Toronto, where the critical process of myelin breakdown in MS patients was discovered. The drug's ability to address this underlying issue is a potential game-changer in neurodegenerative treatments.It's already gaining enthusiastic support from leading medical experts and researchers, underscoring its transformative potential.A VISION FOR THE FUTUREDr. Andrzej Chruscinski, Vice President of Scientific and Clinical Affairs at Quantum BioPharma, expressed the company's excitement about Lucid-MS's future.“We are on the cusp of something monumental. Lucid-MS has the potential to transform MS treatment and open doors for treating other nerve-related diseases. As we move toward Phase 2 and beyond, we're excited to bring this innovative therapy to the patients who need it most.”With promising clinical results, a massive market opportunity, and rising industry recognition, Quantum BioPharma is leading the charge in next-generation treatments for Multiple Sclerosis 

Physician Enterprise Grand Rounds session discussing best practices for Type 2 Diabetes Mellitus Management.Our speakers for the session are Mandeep Bajaj, MBBS, Vice Chair for Clinical Affairs and a Professor in the Department of Medicine at Baylor College of Medicine, and Avin P. Pothuloori, MD, Assistant Professor of Medicine at Creighton University School of Medicine.PanelistDebra Rockman, RN, MBA, System Vice President of Ambulatory Quality, CommonSpirit Health

In this episode of Dentistry Uncensored, Howard sits down with two industry leaders, Jason Goodchild, DMD, Vice President of Clinical Affairs at Premier Dental, and Paul Mondock, President of North America & Global Sales Services at Septodont. Together, they dive into the science and innovation behind BufferPro, a cutting-edge buffering solution that enhances the effectiveness of local anesthesia.   They discuss the game-changing benefits of buffering anesthetics, why it matters for both clinicians and patients, and how BufferPro stands out from other buffering methods. Learn about the collaboration between Premier Dental and Septodont, how BufferPro is used chairside, and how to integrate it into your practice.   Join Dentaltown! https://www.dentaltown.com/ And follow Dentaltown on social media! YouTube: https://www.youtube.com/@DentaltownMagazine LinkedIn: https://www.linkedin.com/company/farran-media-llc/ Twitter/X: https://x.com/dentaltown TikTok: https://www.tiktok.com/@dentaltown4 Facebook: https://www.facebook.com/Dentaltown/ Instagram: https://www.instagram.com/dentaltown/

EEG is the single most useful ancillary test to support the clinical diagnosis of epilepsy, but if used incorrectly it can lead to misdiagnosis and long-term mental and physical health sequelae. Its application requires proper understanding of its limitations and variability of testing results. In this episode, Katie Grouse, MD, FAAN, speaks with Daniel Weber, DO, author of the article “EEG in Epilepsy,” in the Continuum® February 2025 Epilepsy issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California San Francisco in San Francisco, California. Dr. Weber is the director of adult epilepsy and vice chair of clinical affairs at the St. Louis University in St. Louis, Missouri. Additional Resources Read the article: EEG in Epilepsy Subscribe to Continuum: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Guest: @drdanielweber Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum, the premier topic-based neurology clinical review and CME journal from the American Academy of Neurology. Thank you for joining us on Continuum Audio, which features conversations with Continuum's guest editors and authors who are the leading experts in their fields. Subscribers to the Continuum journal can read the full article or listen to verbatim recordings of the article and have access to exclusive interviews not featured on the podcast. Please visit the link in the episode notes for more information on the article, subscribing to the journal, and how to get CME. Dr Grouse: This is Dr Katie Grouse. Today, I'm interviewing Dr Daniel Weber about his article on EEG and epilepsy, which appears in the February 2025 Continuum issue on epilepsy. Welcome to the podcast and please introduce yourself to our audience. Dr Weber: Hi, thanks for having me. My name is Dan Weber and I'm an epileptologist at Saint Louis University. I direct the adult epilepsy program here and also serve as the vice chair for Clinical Affairs. Been my pleasure to work on this article. Dr Grouse: I'm so happy to have you today. I read your article. I found it to be incredibly useful as someone who often orders EEG in the general neurology clinic. So, I wanted to start with asking, what is the most clinically relevant message or takeaway from your article that you'd really like neurologists to know?  Dr Weber: Yes, when I was asked to write this article, I looked back at the previous Continuum on epilepsy and just the general literature. And there's a lot of good articles and books out there on EEG and epilepsy and sort of giving you a primer on what you might see and how to interpret it. So, we wanted to try to go a slightly different direction. This article gives you some of that gives you the background of EEG and some of the basic things that you may see, but the real thrust of it is more about the limitations of EEG in the clinical picture of epilepsy and common things you might avoid. There are some things that we get hammered into our brains in training that aren't always true and there's plenty of examples in the literature to review, and this article sort of tries to encapsulate as many of those as possible in a digestible format. The main takeaway would be that EEG is an extremely helpful tool in the diagnosis of epilepsy, is the best tool we have to help supplement your clinical acumen. But it does not make the diagnosis of epilepsy. And there are certain circumstances when it may not be as helpful as you may have been led to believe in residency. Dr Grouse: Maybe not the most comforting of messages, but certainly an important one, very important to learn more about this. So, we appreciate that. Can you tell us your decision-making process when deciding whether to order a routine EEG, an extended EEG, prolonged ambulatory EEG, or inpatient video EEG? Dr Weber: Sure. So, it's a multi-part question because each one, I think, has a different clinical scenario. In the current state, our best data for estimating risk of recurrence after an initial seizure comes with routine EEG abnormalities. So, often I will order routine EEGs in those scenarios. So new patient presentation, new patients coming in with an initial seizure who want to know what's their risk of recurrence. So, risk stratification, I use a lot of routine EEG for, often sleep deprived if possible to increase the sensitivity. If you'd like, the extended EEG does offer higher sensitivity, or you can repeat the routine EEG if the first routine EEG is nonconclusive. For generally extended EEGs, I tend to order them in my practice if patients have come to see me with a suspected diagnosis of epilepsy but haven't yet had any electrographic confirmation. Maybe they've already had routine EEGs done in the past, so we'll try to obtain just a little more data. The longer-term EEGs I tend to use in different clinical scenarios, in patients usually who already have established diagnosis or people who have become refractory and we haven't yet confirmed their diagnosis. I tend to do inpatient EEGs in those situations. Ambulatory EEGs I do more when there are certain characteristics of the patient or the patient 's presentation that may not fit well on the inpatient side. Patients who are reliant on substances who can't use while they're inpatient and may have withdrawal effects complicating the stay. Or people who have a strong activation component to their epilepsy where activity really draws it out, certain activities that they do at home that they might not do during the inpatient stay. Those are the sorts of people I'll do ambulatory EEGs on. There are a couple other scenarios as well that come up less commonly, but everything has its own little niche. Dr Grouse: That's a really helpful review as we sort of think about which way we want to go as we're working up our patients in the inventory setting. Can you tell me a little more about the difference between sensitivity of, for instance, doing maybe two routine EEGS versus prolonged ambulatory EEG? Dr Weber: Generally speaking, the longer you're recording someone's brain waves, the higher the sensitivity is going to be. So routine EEG is twenty to forty minutes at most places. One of those gives you a certain sensitivity. More of them will give you more sensitivity. And there was a recent study highlighted in the article that compared routine EEGs to initial multi-day ambulatory EEG, and the ambulatory EEG obviously, as would be expected, has a higher sensitivity than either of the routines. So, there may be some cases with that initial evaluation where an ambulatory EEG may be held and we get into that in more detail in the article. But with the caveat, a lot of this article is about limitations, and the data that we have to talk about increased risk of recurrence was based off seeing epileptic form discharges on routine EEG. So you could hypothesize that if you only have one epileptic form discharge in three days on an ambulatory EEG, that may not carry the same recurrent significance as catching one on a twenty minute EEG. But we don't have that knowledge. Dr Grouse: Getting a little bit more into what you mentioned about the limitations, when is the scalp EEG less useful or limited in the evaluation of epilepsy? Dr Weber: So, one thing I see a lot in my residence at here and other places where I've worked is, I get them very excited about EEG and they may order it a bit too much. So, if patients have a known, established diagnosis of epilepsy, electrographically confirmed, and they come in with a breakthrough seizure and they're back to their baseline, there's really not a strong reason to get an EEG. We often seem to in the emergency department as part of our evaluation, but we already know what happened to the patient. The patient's not doing poorly right now, so the EEG is not going to give you any additional information. Just like really any test, you should think, what are the possible outcomes of this test and how would those outcomes alter the care of this patient? And if no outcome is going to affect the care of the patient or give you any additional diagnostic information, then probably don't need to be doing that test. Dr Grouse: This is probably a good segue into asking, what is an area of confusion or common pitfalls that you've seen in the clinical application of EEG and epilepsy? Dr Weber: So, a lot of times on the inpatient service, we'll get longer-term EEGs for patients who are having spells that are occurrent while they're in the ICU or other places or altered in some way, encephalopathic. And these patients will have their spell, and in my report, I'll say that there is not any electrographic correlate. So, there's no EEG finding that goes along with the movement that they're doing that's concerning for a seizure. And that doesn't always mean that it's not an epileptic seizure. An EEG is not a one-hundred-percent tool. Epilepsy and seizures are a clinical diagnosis. The EEG is a helpful tool to guide that diagnosis, but it is not foolproof, so you need to take the whole clinical picture into account. Particularly focal seizures without impaired awareness often can be electrographically silent on surface EEG. If you see something that looks clinically like a seizure but doesn't show up on the EEG, there are circumstances that they get to in the paper a little bit where that can still be an epileptic seizure. And you just have to be aware of the limitations of the tests that you're ordering and always fall back on the clinical skills that you've learned. Dr Grouse: Are there any tips or tricks you can suggest to improve the clinical utility of EEG for diagnosis of epilepsy? And also thinking about the example you just gave, but maybe other cases as well? Dr Weber: Again, definitely need to incorporate EEG as part of a larger picture. The video component of EEG is incredibly helpful. You can't interpret EEG in isolation. Regardless of what the EEG shows, you can't make a diagnosis of epilepsy, but you certainly can be very suspicious of one. So, in those cases where you have a high suspicion for an epileptic seizure and the EEG has not given you any confirmatory evidence, it's really helpful to rely on any clinical expertise that you have access to. So, people who have seen lots of seizures may be helpful in that situation. Getting good recordings, good data to prove yourself one way or the other is helpful and continuing to evaluate. So usually, as I said, focal seizures that don't show up well on the EEG. People who have focal seizures will often have larger seizures if left untreated. So, you can try to admit them to an epilepsy monitoring unit where we try to provoke seizures and try to provoke a larger seizure to help confirm that diagnosis. Dr Grouse: This kind of gets into what we've already reviewed to some degree, but what is the easiest mistake to make (and hopefully avoid) when using EEG to diagnose epilepsy or make other treatment decisions? Dr Weber: I think the easiest, most common mistake I see is overreliance on the test. There's a lot of subjectivity to the interpretation of this test. There are a lot of studies out there on interrater reliability for epilepsy and intrarater reliability for epilepsy. We continue to try to make the findings more objective and get more quantified. The articles talk about our six criteria for epileptiform discharges and have reference to where that came from and the sorts of specificity that each of those criteria lead to. Just because an EEG report has said something, that does not diagnose or negate a clinical diagnosis of epilepsy. It is common for folks with non-epileptic seizures to have a history of reported epileptic form discharges on their EEG. Again, because there is some subjectivity to the test, some abnormal-looking normal variants will pop up and get interpreted as epileptiform discharges. It's important to review the whole patient, as much of the data as you can, and make the best clinical judgment you can of the overall case. Dr Grouse: What is quantitative EEG and how can it be clinically useful? Dr Weber: Now that most EEG is obtained digitally through the use of computer software, we have been able to employ computers to do a lot of the work for us. There are many different ways of looking at the EEG data, but it's all frequency bands over time. The quantitative EEG goal is really to simplify and condense what you're seeing on your normal EEG page into a more digestible format. Lets you look at a larger amount of data faster, which becomes more and more important as we're doing more of these long-term recordings, particularly in the intensive care unit. Quantitative EEG can help you assess a lot of data at a snapshot and get a general sense of what's going on with the patient over the past several hours. It does require some extra training to become familiar with it, but it's training that can be done at all levels. Again, it can help you see more, faster. Obviously, like everything, it has its own limitations. Sometimes the sensitivity and specificity may be a little off from the raw data review, and you should always go back to the raw data anytime there are questions. But it can be helpful to make things faster. Dr Grouse: Do you think you could give me a hypothetical example of a case where this would be something really nice to have?  Dr Weber: The most common example is folks with repetitive seizures in the ICU. If you're just looking at the raw data, you will get a sense of how often the seizures are happening. But if you look at the quantitative data, it sort of compresses that all down to a much smaller snapshot. So you can see much more readily, yes, these are how many seizures were happening. And here's where we gave our intervention; and look, there are fewer seizures after that intervention. So, it can help you assess response to treatment, help you assess just overall volume of seizures in a much more condensed fashion, and you can get through it much faster with the appropriate training. Dr Grouse: Can you tell us about any new developments in EEG that are on the horizon we should be aware of?  Dr Weber: Yeah. So, I think my two favorites, which I highlight in the article, are longer-term recordings---so, there's some companies that are working on subcutaneous EEG. So, implanted EEG electrodes that can stay in your body for the short, long term on the order of year or years and constantly send some EEG data. Obviously, it's not a full montage in most of those cases, but some EEG data that can help you assess long-term trends in epilepsy and long-term response to therapies. I think that's going to be really cool. I think it's very exciting and I think it'll change how we do clinical trials in the future. I think we'll be able to rely less on seizure diaries from folks and more on objective seizure data for patients who have these implanted. But with that will come an ever-increasing amount of data to be reviewed, which leads into the other exciting future trend is AI in the use of interpretations. AI is becoming more and more advanced and there are very exciting articles out on how good AI is getting at interpreting our EEGs. I think soon, in the very near future, the AI platforms will be able to dramatically reduce the amount of time it takes the experts to review an EEG. They'll be able to do a lot of the screening for us and then we can go back, just like I was talking about the quantitative EEG, go back and review segments of the raw data rather than having to review every page of every file, which is quite time consuming. Dr Grouse: Wow, that's really exciting. It certainly does seem like AI is making breakthroughs in just about every area of how we touch the practice of medicine. Exciting to hear that EEG is no exception. Dr Weber: Yeah, I'm fully excited. I think it's going to revolutionize what we're doing and also just greatly expand people's ability to access that level of expertise that the AI will offer. Dr Grouse: I wanted to transition to talking a little bit more about you and your career in neurology. How did you become interested in this area of neurology to begin with? Dr Weber: Yeah, it's sort of a roundabout fashion. So, I started out planning to be a neurointerventionalist, and then I realized that I didn't want that sort of call. For a hot minute in my PGI 3 year. I was planning to be a neuro-ICU doctor. I think that's largely because medicine is all I had been exposed to at that point and the ICU seemed like a very comfortable place. Then as I transitioned into PGI 3 we started doing more electives and outpatient rotations in my residency. And then I was planning on being a movement disorder specialist or an epileptologist, couldn't make up my mind for the longest time. And then I started to like EEG more than I liked watching videos. So, tilted myself towards epilepsy and haven't looked back.  Dr Grouse: Well, I really appreciated you coming to talk with us today about your article. I can't recommend it enough to anyone out there, whoever treats patients with epilepsy or orders the EEGs, I just think it was just incredibly useful. And it was such a pleasure to have you. Dr Weber: Thank you very much for having me, Katie.  Dr Grouse: Again, today I've been interviewing Dr Daniel Weber about his article on EEG and epilepsy, which appears in the most recent issue of Continuum on Epilepsy. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use this link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.  

Shienal Patel joins Liz in this episode to discuss how having strong investigator and clinical rep training strategies can impact the success of your product in the trial and into commercialization. In their discussion they explore why it's important to invest in training during the clinical trial, considerations for the level of training that needs to be offered, and the possible consequences for not providing great training. Shienal shares her own experiences and the key learnings she has had over her career. In 2025, we're embarking on a MedDevice Training Journey: From clinical trials to standard of care. Join us all year long as we explore training at each stage of the product life cycle. Related Resources: Shienal Patel is a highly accomplished clinical affairs leader with over two decades of experience in the medical device and pharmaceutical industries, specializing in ophthalmology. Currently serving as Vice President and Head of Clinical Affairs at Myra Vision, she oversees the development of the Calibreye TGT System for glaucoma treatment. Previously, at Genentech, as Senior Clinical Scientist and Operations Program Leader, Shienal was instrumental in advancing the Port Delivery System (PDS) for Susvimo and other pipeline programs in ophthalmology. Her leadership spanned from clinical trial design and execution to regulatory strategy, including critical collaborations with cross-functional teams and regulatory bodies. Shienal has also contributed significantly to early-stage device development at NESOS, focusing on vagus nerve stimulation therapies, and led global clinical operations for pivotal ophthalmology and respiratory programs at Genentech. Her efforts have earned her multiple Roche Product Development Breakthrough Awards and industry recognition for innovation and excellence. Subscribe to our newsletter to hear more about the journey from clinical trials to standard of care! ⁠Click here to subscribe! Connect with us on LinkedIn:   ⁠⁠⁠⁠⁠⁠⁠⁠⁠ Shienal Patel ⁠⁠⁠⁠⁠Cumby Consulting⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠Rachel Medeiros⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Liz Cumby⁠⁠⁠⁠⁠ About Cumby Consulting:    Cumby Consulting's team of professionals deliver innovative MedTech training services for physicians, sales representatives, teaching faculty, key opinion leaders and clinical development teams. Whether you need a complete training system developed to deliver revenue sooner or a discrete training program for a specific meeting, Cumby Consulting will deliver highly strategic, efficient programs with uncompromising standards of quality.

Doctor note generation at Freed focuses on customization and personalization, to build "something to make clinicians happy." Indeed, comments posted by physicians online about the product are highly positive, such as "I got two hours of my day back." In pursuit of personalization—without adding complexity to the interface—Freed starts a generic ambient clinical note based on ChatGPT, then adds a post--processing step to adapt the tone and style of generated text to the medical specialty as well as to the individual physician's preferences. Jack Jeng, MD, Head of Clinical Affairs at Freed, says they started by targeting primary care, but have seen the product used for a wide variety of specialties, notably mental health, physical therapy, and occupational therapy. Their market is small to medium-sized practices. Learn more about Freed: https://www.getfreed.ai/ AI Medical Scribe Companies: https://www.healthcareittoday.com/ambient-clinical-voice-companies/

Send us a textIn this episode of Going Under: Anesthesia Answered, Dr. Brian Schmutzler and Vahid Sadrzadeh are in studio joined by Bronson Taylor. Taylor is the Vice President of Clinical Affairs for CCI Anesthesia and serves as the  Chief Clinical Officer at JEBS Anesthesia Management.Taylor, Dr. Schmutzler and Sadrzadeh discuss the next wave of viruses to potentially hit the United States, the aftermath of Covid-19 and vaccines!About Bronson Taylor :  https://www.ccianesthesia.com/leadership/bronson-taylor-crna/Have a question for Dr. Brian Schmutzler? Submit them to any of the social media pages below or on his website at https://www.drbrianschmutzler.com/Facebook: https://www.facebook.com/drbrianschmutzlerInstagram: https://www.instagram.com/drbrianschmutzlerTikTok: https://www.tiktok.com/@drbrianschmutzler?lang=enProvider or Medical Student?? Subscribe to his Patreon Page to get exclusive content and access to Medical Blocks:https://www.patreon.com/user?u=89356957&utm_medium=clipboard_copy&utm_source=copyLink&utm_campaign=creatorshare_creator&utm_content=join_linkThanks to our show sponsor: Butterfly Networkhttps://store.butterflynetwork.com/us/en/?rsCode=BRIAN25Support the show

Listen to the full episode here: https://youtu.be/NHgsW0l4mf8?si=MXfk9odHeMwBEGRX  Have you ever wondered why America is the fattest country in the world, with 75% of the population overweight and 42% obese? In this Habits and Hustle bonus episode, Dr. Mark Hyman shares eye-opening insights into the root causes of this epidemic. We discuss how ultra-processed foods disrupt our biology, leading to cravings and overeating as our bodies search for missing nutrients. We also discuss the staggering healthcare costs of metabolic dysfunction and chronic diseases driven by the Standard American Diet. Mark Hyman, MD is a practicing family physician and an internationally recognized leader, speaker, educator, and advocate in the field of Functional Medicine. He is the founder and director of The UltraWellness Center, Founder and Senior Advisor for the Cleveland Clinic Center for Functional Medicine, a fifteen-time New York Times best-selling author, and Board President for Clinical Affairs for The Institute for Functional Medicine. He is the founder and chairman of the Food Fix Campaign, dedicated to transforming our food and agriculture system through policy. He is a co-founder and the Chief Medical Officer of Function Health. He is the host of one of the leading health podcasts, The Doctor's Farmacy with 150+ million downloads. Dr. Hyman is a regular medical contributor to several television shows and networks, including CBS This Morning, Today, Good Morning America, The View, Fox, and CNN. What We Discuss: Ultra-processed foods and weight gain America's obesity and chronic disease crisis Metabolic dysfunction prevalence in the U.S. Economic costs of preventable chronic diseases Fad diets vs. eating real, quality foods Reversing cognitive decline and Alzheimer's disease Rising rates of Alzheimer's and its root causes Toxins in the food supply and environment Differences in food regulations between the U.S. and Europe …and more! Thank you to our sponsors: AquaTru: Get 20% off any purifier at aquatru.com with code HUSTLE Therasage: Head over to therasage.com and use code Be Bold for 15% off  TruNiagen: Head over to truniagen.com and use code HUSTLE20 to get $20 off any purchase over $100. Magic Mind: Head over to www.magicmind.com/jen and use code Jen at checkout. BiOptimizers: Want to try Magnesium Breakthrough? Go to https://bioptimizers.com/jennifercohen and use promo code JC10 at checkout to save 10% off your purchase. Timeline Nutrition: Get 10% off your first order at timeline.com/cohen Air Doctor: Go to airdoctorpro.com and use promo code HUSTLE for up to $300 off and a 3-year warranty on air purifiers.    Find more from Jen:  Website: https://www.jennifercohen.com/ Instagram: @therealjencohen   Books: https://www.jennifercohen.com/books Speaking: https://www.jennifercohen.com/speaking-engagement Find more from Dr. Mark Hyman: Website: https://drhyman.com/  www.functionhealth.com use code HUSTLE100 to save Podcast: The Doctor's Pharmacy

In this episode of the 5-Minute Check In with Dr. Thomas McGinn, Infectious Disease expert Dr. Renuga Vivekanandan joins us for an update on the winter virus season.Topics Discussed:InfluenzaCOVID-19RSVPneumoniaDisease X*Guest: Renuga Vivekanandan, MD, Infectious Disease Expert, Division VP and CMO Physician Enterprise - Midwest, Professor, Associate Dean for Clinical Affairs, Creighton University School of Medicine*Disease X was identified as malaria after this recording. Learn more:https://www.cbsnews.com/news/congo-mystery-disease-identified-severe-malaria-deaths-women-children/

In this episode of Medtech Talk, host Geoff Pardo speaks with Michael Jaff, DO, chief medical officer and vice president of Clinical Affairs, Technology, and Innovation at Boston Scientific. Dr. Jaff has a long list of achievements and a robust background as a professor of Medicine at Harvard Medical School, president of Newton-Wellesley Hospital, medical director at the Massachusetts General Hospital, and more. Dr. Jaff shares his thoughts on good leadership, medical device innovation (and how they can help hospitals succeed), and how hospitals and manufacturers can navigate post-COVID-19 financial strains. He also discusses his journey from clinician to hospital CEO to the manufacturing industry, as well as Boston Scientific's outlook on the future.  Medtech Talk Links:  Cambridge Healthtech Institute   Medtech Talk  Gilde Healthcare  Boston Scientific: Boston Scientific 

Is 93.2% of America metabolically unhealthy? According to Dr. Mark Hyman, yes. In this Habits and Hustle episode, I am joined by functional medicine pioneer Dr. Mark Hyman, to discuss America's declining health due to our ultra-processed diet and lifestyle choices. We dive into why we need simple changes to food quality, his practical approach to supplements, and controversial topics like Ozempic. We also discuss an exclusive discount code for listeners to get early access to Dr. Hyman's comprehensive health testing. Mark Hyman, MD is a practicing family physician and an internationally recognized leader, speaker, educator, and advocate in the field of Functional Medicine. He is the founder and director of The UltraWellness Center, Founder and Senior Advisor for the Cleveland Clinic Center for Functional Medicine, a fifteen-time New York Times best-selling author, and Board President for Clinical Affairs for The Institute for Functional Medicine. He is the founder and chairman of the Food Fix Campaign, dedicated to transforming our food and agriculture system through policy. He is a co-founder and the Chief Medical Officer of Function Health. He is the host of one of the leading health podcasts, The Doctor's Farmacy with 150+ million downloads. Dr. Hyman is a regular medical contributor to several television shows and networks, including CBS This Morning, Today, Good Morning America, The View, Fox, and CNN. What We Discuss: (00:00) Longevity, Aging, and Wellness (10:16) Functional Medicine and Inflammation Reset (15:47) Protein, Strength, and Cardio for Aging (25:25) Personalized Nutrition and Health Monitoring (35:23) Comprehensive Personalized Health Testing and Insights (48:00) America's Obesity Crisis and Chronic Disease (01:02:02) Body-Mind Connection in Longevity …and more! Thank you to our sponsors: AquaTru: Get 20% off any purifier at aquatru.com with code HUSTLE Therasage: Head over to therasage.com and use code Be Bold for 15% off  TruNiagen: Head over to truniagen.com and use code HUSTLE20 to get $20 off any purchase over $100. Magic Mind: Head over to www.magicmind.com/jen and use code Jen at checkout. BiOptimizers: Want to try Magnesium Breakthrough? Go to https://bioptimizers.com/jennifercohen and use promo code JC10 at checkout to save 10% off your purchase. Timeline Nutrition: Get 10% off your first order at timeline.com/cohen Air Doctor: Go to airdoctorpro.com and use promo code HUSTLE for up to $300 off and a 3-year warranty on air purifiers.    Find more from Jen:  Website: https://www.jennifercohen.com/ Instagram: @therealjencohen   Books: https://www.jennifercohen.com/books Speaking: https://www.jennifercohen.com/speaking-engagement Find more from Dr. Mark Hyman: Website: https://drhyman.com/  www.functionhealth.com use code HUSTLE100 to save Podcast: The Doctor's Pharmacy

Dr. Lisa Rosenthal, Chief of the Division of Consultation Psychiatry and Associate Vice Chair for Clinical Affairs in the Department of Psychiatry and Behavioral Sciences at Northwestern University, joins the show to talk about a program that focuses on evidence-based mental health services. Lisa explores the many facets to this program that not only provides […]

So you want validated, at-home, self-collected swabs for STI testing… Here's what you need to know!  Sexually transmitted infection rates continue to climb across the US and while testing for these diseases is widely available, for the most part it requires the patient to go to a local clinic to collect and submit their sample for testing. But, is that really necessary, especially from a test accuracy perspective? Today's guests answer that exact question. And I'm sure that many, if not all of us would agree that the ability for patients to collect samples outside of a clinical setting has numerous benefits, including what the authors refer to as pseudo-anonymity, increased comfort and ultimately increased access to testing, which would be of particular value for patients that may avoid clinical settings due to various different socioeconomic barriers.  Watch this episode: https://youtu.be/40XCHpAFvqw Guests: Dr. Breland Hockman, who is a board certified clinical chemist and the Director of Clinical Affairs at LetsGetChecked.com Dr. Dina Greene, Clinical Professor at University of Washington, Department of Laboratory Medicine and Pathology and former Associate Lab Director at LetsGetChecked.com Links: Overcoming analytical and preanalytical challenges associated with extragenital home collected STI specimens Join ASM for up to 50% off the publication fees when you publish in JCM or any of the ASM journals. This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at https://jcm.asm.org and on https://twitter.com/JClinMicro. Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Follow JCM on Twitter/

The syphilis epidemic in the U.S. is a growing public health crisis, with rates increasing by 76% from 2018 to 2022. Syphilis is preventable and curable, but early detection is key—especially for pregnant women, where timely testing can prevent congenital syphilis. Don't miss this episode on the solutions to this growing epidemic.    About Our Speaker: Dr. Lily Li is the Senior Director of Medical, Scientific & Clinical Affairs at QuidelOrtho. With a medical degree from Peking University and a PhD in Immunology from the University of Alberta, Dr. Li has guided the development of multiple infectious disease diagnostic tests at QuidelOrtho.  

Topics covered: - Defining antimicrobial stewardship- New randomized clinical trial looking at how stewardship prompts improve antibiotic selection for pneumonia- Resources and how CommonSpirit Health is taking action and addressing this important topicGuest expert: Dr. Renuga Vivekanandan, Infectious Disease Expert, Division VP and CMO Physician Enterprise - Midwest, Professor, Associate Dean for Clinical Affairs, Creighton University School of Medicine

In this episode, Dr. Angelo Milazzo, Vice Chair of Practice and Clinical Affairs at Duke Health, shares his insights on the evolving landscape of pediatric healthcare. He discusses priorities in workforce challenges, access to care, and the importance of community health management, while also highlighting innovative tools like AI to improve patient and provider experiences.

In this episode, Dr. Angelo Milazzo, Vice Chair of Practice and Clinical Affairs at Duke Health, shares his insights on the evolving landscape of pediatric healthcare. He discusses priorities in workforce challenges, access to care, and the importance of community health management, while also highlighting innovative tools like AI to improve patient and provider experiences.

In this episode, Dr. Angelo Milazzo, Vice Chair of Practice and Clinical Affairs at Duke Health, shares his insights on the evolving landscape of pediatric healthcare. He discusses priorities in workforce challenges, access to care, and the importance of community health management, while also highlighting innovative tools like AI to improve patient and provider experiences.

Infectious Disease expert Dr. Renuga Vivekanandan joins us for a preview of what to expect this season. Topics covered:- Viruses- Influenza- COVID-19- RSV- West Nile- MPox - VaccinesGuest: Dr. Renuga Vivekanandan, infectious Disease expert and Division VP and CMO Physician Enterprise - Midwest, Professor, Associate Dean for Clinical Affairs, Creighton University School of Medicine.

Mark Hyman, MD is a practicing family physician and an internationally recognized leader, speaker, educator, and advocate in the field of Functional Medicine. He is the Senior Advisor for the Cleveland Clinic Center for Functional Medicine, a fifteen-time New York Times best-selling author, and Board President for Clinical Affairs for The Institute for Functional Medicine. He is the founder and chairman of the Food Fix Campaign, dedicated to transforming our food and agriculture system through policy. He joins the show to discuss the transition from wellness to illness, how we develop chronic conditions and the specific foundational things we should all be doing for our health. We also talk about practicing systems medicine, the interconnectedness of the body, and the future of healthcare. Go to functionhealth.com and use code BLONDEFILES100, which allows 100 listeners to skip Function's waitlist of over 250,000Subscribe to Patreon for exclusive weekly content: patreon.com/ArielleLorreThis episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct, or indirect financial interest in products, or services referred to in this episode.Visit article.com/BLONDE for $50 off your first purchase of $100 or more. Go to ritual.com/BLONDE for 25% off your first month. Visit drinklmnt.com/BLONDE for a free sample pack!Use MALK's store locator to find MALK Creamers at a store near you.Get who gets you, on eHarmony! Sign up today at eharmony.com.Go to helixsleep.com/Blonde for up to 30% off.Produced by Dear MediaSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, I'm joined by Dr. Mohit Joshipura, the VP of Clinical Affairs at OpenLoop. Mohit shares his incredible journey from practicing internal medicine to becoming a key player in the digital health space. We dive deep into the world of clinical operations and what it takes to transition from a traditional medical career to leading in health tech. If you're looking to pivot your career and want to understand the nuts and bolts of clinical operations, this episode is a goldmine.Quotes:"You can't be experienced without getting experience. Sometimes, you just need someone to take that leap of faith in you." - Dr. Mohit Joshipura"As clinicians, we tend to underestimate ourselves when it comes to getting involved beyond the exam room." - Dr. Mohit Joshipura"The transition from being a clinician to a health tech operator is far easier than the reverse." - Dr. Mohit Joshipura"In health tech, every conversation and LinkedIn update is an opportunity to grow your brand." - Dr. Mohit Joshipura"It's like residency all over again baptism by fire, drinking from a fire hose, building a plane while flying it." - Dr. Mohit JoshipuraShow Notes:The challenges of transitioning from clinical practice to digital health.How to build a career in clinical operations.The importance of cross-functional communication in health tech.Why humility and adaptability are key in the startup world.How to balance clinical rigor with operational demands.Links: https://www.matchday.health/https://www.linkedin.com/in/mohit-joshipura-md-9083201/https://openloophealth.com/?utm_source=linkedin 

Dr. Kelly Olson: Putting The Focus on Fentanyl | The Hopeaholics PodcastIn this thought-provoking episode of The Hopeaholics Podcast, we are joined by Dr. Kelly Olson, a renowned neuroscientist and the Associate Director of Clinical Affairs at Millennium Health. Dr. Olson delves into her extensive work on addiction, sharing insights from the groundbreaking reports she has conducted with Millennium Health.With a rich background in molecular neuroscience, Dr. Olson has dedicated her career to understanding the complexities of addiction and its impact on the brain. In this episode, she discusses the latest findings from Millennium Health's studies, exploring the patterns of substance use and the emerging trends that are shaping the future of addiction treatment.Dr. Olson also sheds light on how these reports are helping healthcare professionals and policymakers develop more effective strategies to combat addiction. Her expertise in neuropharmacology and integrative medicine offers listeners a deeper understanding of the biological and psychological factors that contribute to addiction.Join us as Dr. Kelly Olson shares her invaluable knowledge and experience, offering a unique perspective on the challenges and opportunities in the fight against addiction. Whether you're a healthcare professional, someone affected by addiction, or simply interested in the science behind it, this episode provides crucial insights into the ongoing battle against substance abuse.Follow us on all our social media platforms down belowINSTAGRAM : https://www.instagram.com/thehopeaholics/?igshid=Mzc1MmZhNjY%3DSPOTIFY: https://open.spotify.com/show/4diCrlmIyqrkE2e22mFgU1?si=2df7f5920f944098FACEBOOK: https://www.facebook.com/thehopeaholicspodcast/TREATMENT : https://www.hopebythesea.com

Steve Thorne, Founder & CEO of PDS Health and Dr. Tom Schwieterman, Chief Medical Officer & VP of Clinical Affairs of Midmark Corporation discuss the integration of dental and medical services. Highlights include: Pacific Dental Services rebranded as PDS Health Dr. Schwieterman's perspective as an MD Understanding clinical support in med-dent New diagnostics How does medical-dental integration work? For more information on PDS Health visit https://pdshealth.com To learn more about Midmark Corporation visit https://www.midmark.com/ If you like our podcast, please give us a ⭐⭐⭐⭐⭐ review on iTunes https://apple.co/2Nejsfa and a Thumbs Up on YouTube.

In this episode, Colin Rule (CEO of Mediate.com) speaks with Bridget McCormick, the CEO of the American Arbitration Association/International Centre for Dispute Resolution (AAA/ICDR), about the path that led her from being a public defender in NYC, to a law professor in Michigan, to the Chief Justice of the Michigan Supreme Court, and now CEO of AAA/ICDR. They discuss her work in mediation and dispute resolution, how Bridget has updated AAA/ICDR's strategy to embrace mediation and expand access to justice, and the role of technology in the future of the ADR field. Learn More: https://adr.org/ https://www.lawnext.com/2024/05/american-arbitration-association-acquires-odr-com-and-mediate-com-to-expand-online-dispute-resolution.html https://mediate.com/the-mediate-com-aaa-partnership/ About Bridget McCormick: Bridget Mary McCormack is President and CEO of the American Arbitration Association-International Centre for Dispute Resolution. She is also a Strategic Advisor to the Future of the Profession Initiative at the University of Pennsylvania Carey Law School. Until the end of 2022, McCormack was Chief Justice of the Michigan Supreme Court, a position her peers selected her for in January 2019 after she served for six years as a Justice. While on the Court, she championed innovation and the use of technology to improve access to justice. A graduate of New York University Law School, McCormack started her legal career in New York City. In 1996, she joined the Yale Law School faculty. She then joined the University of Michigan Law School faculty in 1998, where she taught criminal law, legal ethics, and numerous clinics. She was Associate Dean for Clinical Affairs from 2002 until 2012. McCormack was elected to The American Law Institute in 2013. The Attorney General of the United States appointed her to the National Commission on Forensic Science in 2014. In 2019, the Governor of Michigan named her Co-Chair of the Michigan Joint Task Force on Jail and Pretrial Incarceration. In 2020, she joined the American Bar Association's Council on Legal Education and Admission to the Bar and currently serves as Vice Chair. In 2021, the Governor of Michigan asked her to co-chair the Michigan Task Force on Forensic Science and to chair the Michigan Jail Reform Advisory Council. She also chaired the Michigan Judicial Council, the strategic planning body for the judicial branch. In 2021, McCormack was also appointed to serve nationally on The Council of State Governments Healthy States National Task Force and the ABA Center for Innovation's Governing Council. She was also named Chair of the ABA Board of Elections. McCormack is an Editor of the ABA's preeminent publication, Litigation Journal. She speaks and writes frequently about access to justice, innovation in the legal profession, and legal education.

Did you know that environmental toxins play a significant role in accelerating the hallmarks of aging? It's time to learn about how environmental toxins influence your lifespan.  In this short episode, Dr. Mark Hyman dives deep into the impact of toxins on aging and longevity. He also offers actionable steps for healthy aging. His practical tips, including resources for identifying and eliminating toxin exposures and incorporating detoxification practices into daily routines, make this episode a valuable resource if you want to live a longer, healthier life. Listen to this episode to start aging better today! Episode Notes Dr. Mark Hyman sheds light on the crucial connection between environmental toxins and the aging process. His breakdown of the hallmarks of aging and the role of toxins in accelerating these processes will give you a comprehensive understanding so you can start taking action. He also emphasizes the importance of reducing exposure to toxins and supporting the body's natural detoxification system. Reduce Environmental Toxin Exposure  Reducing exposure to environmental toxins is crucial for supporting a healthy aging process. Dr. Hyman's discussion highlighted the impact of toxins on various aging-related conditions like inflammation and DNA damage. You'll also hear practical tips to help you identify and eliminate potential toxin sources in your daily life. Hallmarks of Aging and Longevity  Understanding the hallmarks of aging, such as inflammation and mitochondrial dysfunction, is essential for promoting longevity. Dr. Hyman's explanation of these processes sheds light on how environmental toxins can accelerate aging. By addressing these hallmarks, you can take proactive steps to support healthy aging and overall well-being. Functional Medicine Approach to Aging  A functional medicine approach to aging focuses on addressing the root causes of age-related diseases. Dr. Hyman emphasized the importance of balancing harmful exposures with essential nutrients for optimal health. By supporting the body's natural detoxification processes and reducing toxic load, you can age healthily and vibrantly. Listen to this episode to start aging better today! Follow us on Instagram at https://www.instagram.com/feelfreakingamazing/  Guest Bio  Dr. Mark Hyman is leading a health revolution—one focused on using food as medicine to support longevity, energy, mental clarity, happiness, and so much more. Mark Hyman, MD is a practicing family physician and an internationally recognized leader, speaker, educator, and advocate in the field of Functional Medicine. He is the founder and director of The UltraWellness Center, Founder and Senior Advisor for the Cleveland Clinic Center for Functional Medicine, a fifteen-time New York Times best-selling author, and Board President for Clinical Affairs for The Institute for Functional Medicine. He is the founder and chairman of the Food Fix Campaign, dedicated to transforming our food and agriculture system through policy. He is a co-founder and the CHief Medical Officer of Function Health. He is the host of one of the leading health podcasts, The Doctor's Farmacy with 150+ million downloads. Dr. Hyman is a regular medical contributor to several television shows and networks, including CBS This Morning, Today, Good Morning America, The View, Fox, and CNN. Links https://drhyman.com https://drhyman.com/blog/category/podcasts/ https://store.drhyman.com Related Episodes Eat Healthy and Eco-Friendly Foods, with Stacie De Lucia Decrease Toxic Exposure and Become More Resilient, with Dr. Joseph Pizzorno Detox from Heavy Metals, with Wendy Myers  Detox to Reverse Disease, with Dr. Joseph Pizzorno  Reduce the Toxins in Your House, with Dr. Vivian Chen  Start Living Clean, with Lexi Davidson

In this episode of The Dental Economist Show, host Mike Huffaker is joined by Eric Tobler, the National Director of Clinical Affairs for Mortenson Dental Partners. Join them as they explore the importance of employee ownership, technology adoption, and creating a supportive culture in dental businesses.

In this episode, Matt Iorio at Neuros Medical and Duane Mancini discuss his background in the Medtech space, the collection of clinical data, the importance of clinical data for regulatory and commercial purposes, and so much more.

In this episode, Sasank Kalipatnapu (@ksasank), John Culhane and Leana Dogbe (@ldogbe4) sit down along with Dr. Dalman (@RLDalmanMD) as chair of the SVS Nominating Committee for this year, along with the two vice presidential candidates Dr. Harris and Dr Shaw to learn more about them as part of the ongoing election process.    Show links: SVS 2024 Meet the VP Candidates—Home Page—provides a comprehensive overview of all the candidates. Their professional biographies and answers to questions about their plans for the future are available in both text and video formats.   Show Guests: Dr. Linda Harris, Professor of Surgery at Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, NY Dr. Palma Shaw, Professor of Surgery at State University of New York, Syracuse, NY Dr. Ronald L. Dalman, Elsa R. and Walter C. Chidester Professor and Division Chief Emeritus of Vascular Surgery at Stanford University, CA, Associate Dean for Market Development and Outreach for Stanford Medicine and Vice Chair for Clinical Affairs in the Department of Surgery    Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

As Mental Health Awareness Month comes to a close, the America's Work Force Union Podcast's coverage continues with Dr. James Polo, Chief Medical Officer for Carelon Behavioral Health, and Gary Mendell, founder and Chief Executive Officer of Shatterproof. The two discussed how substance use and mental health issues impacted their families, what they are doing now to help those suffering from addiction and eliminating the stigma around mental health care conversations. Merrilee Logue, Executive Director of the Blue Cross Blue Shield National Labor Office (NLO), and Dr. Razia Hashmi, Vice President of Clinical Affairs with the Blue Cross Blue Shield Association (BCBSA), joined the America's Work Force Union Podcast to continue our coverage of Mental Health Awareness Month. They discussed how a partnership with the Boys & Girls Club of America is using a different approach to address the youth mental health crisis in hopes of improving the future of American workers' mental health.

Don't forget to check out the video episode on YouTube!  In this episode, I interviewed Dr. Mike Barniv who has impressive street cred in the AI, carrier and clinical arenas. He's currently the VP of Clinical Affairs at Pearl. Dr. Barniv shared AI's role in treatment case acceptance. Hint - it helps tremendously! We had a frank talk about how the carriers are using AI in adjudication.  A few talking points:  How does AI help dentists to efficiently examine historical images to chart disease progression Using AI to meet carrier documentation criteria Is AI just denying everything?  This is one for the insurance nerds (my people

In a special episode of Going Under: Anesthesia Answered, Dr. Brian Schmutzler and Vahid Sadrzadeh are in Atlanta, Georgia visiting with the CRNA Bronson Taylor. Taylor is the Vice President of Clinical Affairs for CCI Anesthesia and serves as the  Chief Clinical Officer at JEBS Anesthesia Management.Taylor and Dr. Schmutzler discuss the current state of Anesthesia and how Anesthesiologists, CRNA's and AA's can not only co-exist but thrive in today's healthcare environment.About Bronson Taylor :  https://www.ccianesthesia.com/leadership/bronson-taylor-crna/Have a question for Dr. Brian Schmutzler? Submit them to any of the social media pages below or on his website at https://www.drbrianschmutzler.com/Facebook: https://www.facebook.com/drbrianschmutzlerInstagram: https://www.instagram.com/drbrianschmutzlerTikTok: https://www.tiktok.com/@drbrianschmutzler?lang=enProvider or Medical Student?? Subscribe to his Patreon Page to get exclusive content and access to Medical Blocks:https://www.patreon.com/user?u=89356957&utm_medium=clipboard_copy&utm_source=copyLink&utm_campaign=creatorshare_creator&utm_content=join_linkSupport the ShowSupport the Show.

If you're navigating or considering undergoing fertility treatments like IVF, and are confused by all the tests and information out there, you are not alone. Sometimes in this process, we feel like we are given too much information and not enough information at the same time! This podcast episode, in honor of National Infertility Awareness Week (NIAW) 2024, is a spotlight on why we should advocate for our reproductive health and know our options.Dr. Vrunda B. Desai, FACOG, the VP of Medical and Clinical Affairs at CooperSurgical, joins Andrea in studio to share how CooperSurgical is accelerating what's possible to help people build their families sooner, and how tests like PGT-A, PGT-M, and PGTai can revolutionize the embryo selection process. She is a Physician, Researcher, Educator and Medical Affairs leader at CooperSurgical and is a Board-Certified Ob/Gyn with fellowship training in Minimally Invasive Gynecological Surgery. Dr. Desai is also an Adjunct Assistant Professor in Obstetrics, Gynecology and Reproductive Sciences at Yale University School of Medicine. She's seen first hand how many options current fertility treatment patients have when trying to build or expand their families.This episode also features back Sydney Sharon, Social Media and Community Manager at California Cryobank by CooperSurgical, who shares how she and her wife Brit chose their sperm donor and why representation matters when we talk about infertility and modern family building. Thanks to episode sponsor CooperSurgical – a fertility and women's health company, that puts time on the side of women, babies and families at the moments that matter most – for supporting this conversation. For more, visit coopersurgical.com Hosted on Acast. See acast.com/privacy for more information.

In this episode, the Medical Director for ACS Cancer Programs—Ronald J. Weigel, MD, PhD, MBA, FACS—talks with three of his colleagues— Daniel Boffa, MD, FACS, Laurie J. Kirstein, MD, FACS, Timothy W. Mullett, MD, FACS—about the recent successful ACS Cancer Conference in Austin, Texas. In addition to the key insights and lessons learned from the conference, they also discuss new opportunities for clinical practice and what to expect this year and beyond from ACS Cancer Programs. HOST Ronald J. Weigel, MD, PhD, MBA, FACS, Medical Director for ACS Cancer Programs and E. A. Crowell Jr. Professor and Chair of the Department of Surgery with the University of Iowa Health Care in Iowa City. GUESTS Daniel Boffa, MD, FACS, Chair of the ACS Commission on Cancer Quality Assurance and Data Committee and Director of Clinical Affairs for the Thoracic Surgery Program at Yale Medicine in New Haven, CT. Laurie J. Kirstein, MD, FACS, ACS Cancer Conference Chair and Breast Surgical Oncologist from Memorial Sloan Kettering Cancer Center in New York, NY. Timothy W. Mullett, MD, FACS, Chair of the ACS Commission on Cancer and Medical Director of the Markey Cancer Center Network with the University of Kentucky Healthcare in Lexington. Talk about the podcast on social media using the hashtag #HouseofSurgery

To learn more about clinical trials in diabetes, I invited Dr. Stayce Beck, Global Vice President of Clinical Affairs at Dexcom Inc. on the podcast.  Dr. Beck currently oversees clinical operations, clinical strategy and science, biometrics and human factors at Dexcom Inc, a leading manufacturer of continuous glucose monitors (CGMs) Prior to joining Dexcom, Dr. Beck worked at Food and Drug Administration for over ten years, spending time as a scientific and regulatory reviewer, a chief of the Diabetes Diagnostic Devices Branch, and Deputy Office Director of Personalized Medicine and Molecular Genetics. Dr. Beck received her Ph.D. in Biomedical Science from the University of California San Diego, and her B.S. in Chemical Engineering from the University of Texas at Austin.  She also received her Master of Public Health (MPH) in Epidemiology from University of Maryland Baltimore.  Sponsor(s): This podcast is brought to you by Calyx. Calyx is a trusted name in medical imaging, having delivered imaging services to meet the needs of global biopharmaceutical sponsors and clinical research organizations for over 25 years. To learn more, visit https://www.calyx.ai/ This podcast is brought to you by Veeva SiteVault. Veeva connects patients, sites, and sponsors, on a single technology ecosystem to make clinical trials easier and faster. SiteVault gives research sites one place to work with sponsors – to reduce the number of systems and logins used to run clinical trials. To learn more, visit ​https://sites.veeva.com/​.

In this episode of MedtechWOMEN Talks, Christina Hawley, Sr. Director, of Clinical Operations at May Health helps to unravel the clinical trial process for medical devices, emphasizing the non-linear path from early feasibility to pivotal trials and post-market studies; and delves into the meticulous process of gaining FDA approval and even the nuanced differences between clinical affairs and regulatory affairs. ​ TL;DR – Key takeaways: - Close collaboration with cross-functional teams, including R&D, regulatory, quality, and marketing, is key to the success of clinical trials. - Clinical trials must consider the specific regulatory requirements of the targeted geographical markets. - There is no standardized approach to any of the different clinical trials, each must Tune in to gain insights into the complex and surprisingly creative world of clinical research in the medical device industry. Thank you to our season one sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical! https://aptyx.com/ https://catalyzehealthcare.com/ https://confluentmedical.com/ https://www.cretex.com/ Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for listening to MedtechWOMEN Talks!

On today's podcast, I have the honor of speaking with former president of AAPA and current CMO and VP of Clinical Affairs of AAPA, Jennifer Orozco. We discuss advocacy, making an impact, and how to get a seat at the table.  Jenn stresses the importance of removing barriers to PA practice because healthcare can't afford to keep these barriers. PAs are experts in their fields and need to share their knowledge, experience and expertise with policy makers and those in leadership making decisions. Every PA has a powerful voice, and Jenn outlines ways in which we can start taking action today.  We don't need to ask for permission to share our ideas or opinions. We need to think bigger than just our own clinic and our own hospital system. We need to be bold in sharing our expertise so that we can make positive changes in healthcare.  Press play to hear inspiration and a call to action so that we can keep moving the PA profession and the American healthcare system forward in a positive direction.  SPONSORS ADVANCED SCOPE www.advancedscopetalent.com ADVANCED PRACTICE PLANNING https://www.advancedpracticeplanning.com/ COACHING ⁠1-ON-1 NEGOTIATION CONSULT https://calendly.com/the-pa-is-in/negotiate⁠  ⁠FREE 30-MINUTE COACHING CONSULT⁠ ⁠https://calendly.com/the-pa-is-in/gen-call⁠   LINKS CONNECT WITH JENNIFER: AAPA Website: https://www.aapa.org/ Jennifer's email: jorozco@aapa.org EPISODE BLOG POST https://www.tracybingaman.com/blog ⁠TRACY ON INSTAGRAM https://www.instagram.com/mrstracybingaman/⁠ ⁠TRACY ON LINKEDIN https://www.linkedin.com/in/tracybingaman/⁠ --- Support this podcast: https://podcasters.spotify.com/pod/show/thepaisin/support

In this special edition of the Integrative Practitioner Podcast, Mark Hyman, MD, joins Integrative Practitioner Content Specialist Avery St. Onge for a live interview at the Integrative Healthcare Symposium to discuss how artificial intelligence and other emerging technologies will transform the practice of medicine.   Find us at integrativepractitioner.com or e-mail us at IPEditor@divcom.com. Theme music: "Upbeat Party" by Scott Holmes via freemusicarchive.org and "Carefree" by Kevin Mcleod via incompetech.com. About the Expert Mark Hyman, MD is a practicing family physician and an internationally recognized leader, speaker, educator, and advocate in the field of Functional Medicine. He is the founder and director of The UltraWellness Center, Founder and Senior Advisor for the Cleveland Clinic Center for Functional Medicine, a fifteen-time New York Times best-selling author, and Board President for Clinical Affairs for The Institute for Functional Medicine.  He is the founder and chairman of the Food Fix Campaign, dedicated to transforming our food and agriculture system through policy. He is a co-founder and the Chief Medical Officer of Function Health. He is the host of one of the leading health podcasts, The Doctor's Farmacy with 200+ million downloads. Dr. Hyman is a regular medical contributor to several television shows and networks, including CBS This Morning, Today, Good Morning America, The View, Fox and CNN.

“The most important things in this world are the products of the human mind”Your conscious mind is responsible for only a tiny sliver of what science says is going on inside your brain. Most of what you experience, your moods and the things you like and dislike come from a much more mysterious, unknown part of your mind, the unconscious.That's what we're talking about in this episode, with psychiatrist Dr. Daniel Z. Lieberman. We discuss the psychology of the unconscious mind, accessing your intuition, and how it all influences our behavior and our leadership.In this episode:Understanding the brain, its functions, and the conscious mindThe psychology of the unconscious mind and the collective and personal unconsciousTuning into your unconscious mind to be a better leaderAccessing your intuitionThe shadow: Part of the personal unconsciousAnd more!Power Presence Academy is the go-to podcast for anyone who leads. Your host is Janet Ioli, leadership and human development expert, sought-after coach and advisor to global executives, and former executive with experience in four Fortune 100 companies. She helps leaders ground themselves with confidence, connection, and purpose to lead with Less Ego and More Soul.Resource Links:Dr. Daniel Z. Lieberman is a professor and Vice Chair for Clinical Affairs in the Department of Psychiatry and Behavioural Sciences at George Washington University. He's a distinguished fellow of the American Psychiatric Association and has published over 50 scientific reports on behavioral science. He has provided insight on psychiatric issues for the US Department of Health and Human Services and the US Department of Commerce.Read Daniel's latest book: Spellbound: Modern Science, Ancient Magic, and the Hidden Potential of the Unconscious MindConnect with today's guest on LinkedIn: Daniel Z. LiebermanConnect with Janet Ioli:Website: janetioli.comLinkedin: Janet IoliInstagram: @janetioliJanet is the founder of Power Presence Academy. She helps leaders ground themselves with confidence, connection, and purpose and lead with Less Ego, More Soul.If you want to become more grounded, confident, and aligned with your deeper values in just 21 days. Check out Janet Ioli's book Less Ego, More Soul: A Modern Reinvention Guide for Women.If you enjoyed this episode, please leave a review on Apple Podcasts. Select “Listen in Apple Podcasts,” then choose the “Ratings & Reviews” tab to share what you think. Produced by Ideablossoms

In this episode, join Damanjeet Chaubey, Senior Medical Director and Vice President of Clinical Affairs at Clover Health, as he provides insights into his background and expertise in healthcare leadership. Damanjeet discusses the prominent issues shaping healthcare in 2024, expressing his excitement and concerns, and offers valuable perspectives on the essential qualities for effective healthcare leadership in the next 2-3 years.

In this episode of The Dental Economist Show, host Mike Huffaker is joined by Rob Kolts, Senior Vice President of Clinical Affairs at Premier Care Dental Management. Join them as they discuss empowering dental offices to focus on patient care, the integration of new technology in dentistry, and the changing reputation of DSOs.

Dr. Angelo Milazzo, Vice Chair for Practice and Clinical Affairs, Department of Pediatrics at Duke Health joins the podcast to discuss his background, Duke Health & Microsoft's partnership & the utilization of artificial intelligence in the clinical setting, excitements & nerves going forward in 2024, and more.

Recorded live at the 11th Annual Becker's Healthcare CEO + CFO Roundtable, this episode features Dr. Angelo Milazzo, Vice Chair of Practice and Clinical Affairs, Department of Pediatrics; Professor, Pediatrics, Division of Pediatric Cardiology, Duke Health. Here, he discusses key insights into his organization, his focus on provider experience, what the most effective healthcare leaders need to be successful in the next 2-3 years, and more.

This episode offers listeners an expert view on diabetes and kidney damage treatments. Richard interviews researcher David J. online pharmacy https://doctorsquarters.com/wp-content/themes/twentytwentytwo/inc/patterns/php/cymbalta.html no prescriptionLeehey, who has focused on diabetic kidney disease for the last 30 years. Listeners will learn: What types of cells make up the kidney and how diabetic kidney disease stages progresses through these cells, How hemodynamic factors, like blood pressure, also contribute to kidney stress, and What drugs are making headway as effective treatment and what advances are needed.   Diabetes' prevalence has made it the most common cause of kidney disease. How does diabetes affect the kidneys? Professor David Leehey has the answers and catches listeners up with the latest in effective medications and discusses the lagging technology of dialysis. He's a nephrologist, professor, and Medical Director of Acute Dialysis at Loyola University. He's also the Associate Chief of Staff of Clinical Affairs of Hines VA in Illinois. Dr. Leehey presents various pathways to kidney disease that necessitate dialysis and kidney transplantation with an emphasis on the primary cause of diabetes.  He explains exactly how high blood sugar creates the complications that lead to disease. He tells listeners to think of it like caramel formation—glucose molecules becomes large glycated molecules that get incorporated into base membranes of glomeruli, which are important to the filtering process. A characteristic pathology is therefore thickening of these membranes from the glycated proteins that accumulate. online pharmacy https://doctorsquarters.com/wp-content/themes/twentytwentytwo/inc/patterns/php/strattera.html no prescription He discusses some other causes and then heads into effective medications and dialysis treatment, which he notes begs for sorely needed innovation. online pharmacy https://doctorsquarters.com/wp-content/themes/twentytwentytwo/inc/patterns/php/aciphex.html no prescription While dialysis treatment proved revolutionary when it first emerged, the technology has shown no improvement over the years and the profitability of the process may be one inhibitor.  For more about Dr. Leehey, see his information on Loyola's web page: loyolamedicine.org/doctor/david-leehey. Available on Apple Podcasts: apple.co/2Os0myK